Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Covalently-cross-linked-oligonucleotides

 Device and method for the electrophoretic separation of macromolecules
The invention relates to an electrophoresis device and an electrophoresis method for the separation ...


 Superfusion apparatus
It is an object of the present invention to provide a superfusion apparatus for use in receptor ...


 Method and apparatus for administration of anticoagulant to red cell suspension output of a blood separator
OF THE PREFERRED EMBODIMENTS Referring now to the drawings, particularly to FIG. 1, there is ...


 Electroporation device
I claim: 1. An electroporation apparatus for electroporating living cells with molecules comprising:...


 Implantable electroporation method and apparatus for drug and gene delivery
Accordingly, it is the primary object of the present invention to provide an improved method of ...


 Flow electroporation chamber with electrodes having a crystalline metal nitride coating
The present invention provides improved electrodes for use in generating an electrical field in a ...


 Solely pollen-specific promoter
What is claimed is: 1. An isolated solely pollen-specific promoter derived from Arabidopsis ...


 Gene transfer using transformed, neodetermined, embryonic cells
This invention relates to the preparation of carrier cells capable of delivering genetic material ...


 Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
The present invention provides methods and compositions for inhibiting loss of bone mass, and/or ...


 Imidazole-containing cationic amphiphiles for intracellular delivery of therapeutic molecules
The present invention provides for cationic amphiphiles that are particularly effective to ...


 Covalently cross-linked oligonucleotides

Details
Inventors: Cook, Phillip Dan; Manoharan, Muthiah; Bruice, Thomas;
Assignee: ISIS Pharmaceuticals, Inc. (Carlsbad, CA)
Primary Examiner: Elliott; George C.
Assistant Examiner: Larson; Thomas G.
Attorney, Agent or Firm: Woodcock Washburn Kurtz Mackiewicz & Norris LLP

Covalent cross-linkages for two oligonucleotide strands or for first and second regions of a single oligonucleotide strand connect sugar moieties of nucleotides on the respective strands or the regions of the single strand. The cross-linkages are connected to at least one strand or region via a space-spanning group. The cross-linkage also can be connected to the other strand or other region via a space-spanning group or via an abasic site located on the other strand or other region.

DETAILED DESCRIPTION OF THE INVENTION In accordance with the objects of this invention novel, covalently cross-linked oligonucleotide strands are disclosed.
Preferably such strands are "duplexed" or "complementary" along at least a portion of their length.
In the context of this invention the terminology "duplex strands" or "complementary strands" or like terminology refers in a first instance to two separate strands wherein at least one nucleotide or nucleotide sequence on one of the strands is complementary to and specifically hybridizable with an opposing nucleotide or nucleotide sequence on the other strand.
In a second instance, this terminology refers to two sections or sequence regions of a single strand that are spaced from one another by a distance sufficient for the strand to fold onto itself and permit hybridization of complementary nucleotides in the respective sequence regions.
Folded, self-hybridizing, single strands form hairpin loop, stem loop, interior loop or bulge type structures as a result of such hybridization.
Further in the context of this invention, the term "oligonucleotide" refers to polynucleotides formed from a plurality of joined nucleotide units.
In certain instances, the nucleotides are formed from naturally occurring bases and pentofuranosyl sugars groups and are joined together via native inter-nucleoside phosphodiester linkages.
The term "oligonucleotide" thus effectively includes naturally occurring or synthetic species formed from naturally occurring subunits.
The term "oligonucleotide" also includes structures formed from modified or non-naturally occurring nucleotide subunits.
Modifications can occur on the base portion of a nucleotide, on a sugar portion,of a nucleotide or on the linkage joining one nucleotide to the next.
In addition, modifications can be made wherein nucleoside units are joined together with connecting groups that substitute for the inter-nucleoside phosphate linkages.
Inter-nucleoside connecting groups, which are to be distinguished from the cross-linkages of the invention, include --O--CH



Related patents
  Methods of inducing cancer cell death and tumor regression
The present invention provides methods of treating cancer in a patient (e.g., a mammal such as a human) in need of such treatment, comprising administering an effective ...
  Injectable hyaluronic acid derivative with pharmaceuticals/cells
OF THE INVENTION The present invention concerns injectable, biocompatible and biodegradable compositions containing at least one hyaluronic acid benzyl ester derivative ...
  Modification of polymer surfaces and molecular immobilization by photoreaction
OF THE INVENTION To obviate disadvantages associated with the modification methods presently existing, the object of the present invention is to provide a method for ...
  Wound and skin care compositions
What is claimed: 1. A composition comprising a dermatologically acceptable carrier and an effective amount of a hydroxy acid compound, present in a concentration of ...
  Water treatment apparatus
The embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows: 1. Water purification apparatus for purifying dirty water,...
  Membrane cell
What we claim is: 1. A monopolar filter press electrolytic cell suitable for use in the electrolysis of an aqueous alkali metal halide solution (brine) to produce an ...
  Encapsulating biological active substances into erythrocytes
We claim: 1. A process for the encapsulation in human or animal erythrocytes of at least one substance having a biological activity utilizing a dialysis element having a ...
  Flow chamber and electro-manipulator incorporating same
Accordingly, an object of the present invention is to provide a flow chamber and an electro-manipulator incorporating the same which can be operated easily, and which ...
  Electroblotting technique for transferring specimens from a polyacrylamide electrophoresis or like gel onto a membrane
What is claimed is: 1. An apparatus especially suitable for transferring a biological specimen from a polyacrylamide electrophoresis or like gel onto a support sheet by ...
  Probe for electrofusion, electroporation, or like procedure
The present invention provides a structure and method for treating samples in a well tray. Briefly, the invention contemplates the provision of a probe that is specially ...

0.014

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved